Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Syndax Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.

Get SNDX alerts

About Michael Metzger

Michael Metzger is recorded as CEO at Syndax Pharmaceuticals Inc (SNDX). Michael Metzger has spoken on 20 earnings calls across 1 company, most recently for Syndax Pharmaceuticals Inc on August 4, 2026. Syndax Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Syndax Pharmaceuticals Inc includes Michael A. Metzger (CEO and Board Member), Aaron A. Ondrey (CFO and Chief Accounting Officer), Keith A. Goldan (CFO) and 6 others.

Michael Metzger on recent calls

“The Syndax team delivered another quarter of solid commercial results and progress across our growing pipeline of programs, targeting areas of high unmet need and substantial commercial opportunity.”
CEO, Syndax Pharmaceuticals Inc Q2 FY2026 Earnings Call ·
“I'm pleased to share our fourth quarter and full year financial results following a transformational year that positioned Syndex for continued growth in 2026 and beyond.”
CEO, Syndax Pharmaceuticals Inc Q4 FY2025 Earnings Call ·
“The third quarter was another outstanding period for Syndax in terms of commercial and portfolio execution.”
CEO, Syndax Pharmaceuticals Inc Q3 FY2025 Earnings Call ·
“Starting with Slide 3, the first half of 2025 has been a transformative time for Syndax, characterized by exceptional execution in both our commercial and pipeline areas.”
CEO, Syndax Pharmaceuticals Inc Q2 FY2025 Earnings Call ·
“I'm pleased to report that Syndax delivered another outstanding quarter of execution as a commercial company with two first and best-in-class medicines on the market and a robust pipeline of clinical development programs designed to unlock the multibillion-dollar opportunities for both of our medicines.”
CEO, Syndax Pharmaceuticals Inc Q1 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Syndax Pharmaceuticals Inc

Recent activity

Show 8 earlier activities